Cargando…
The effect of tranexamic acid on intraoperative blood loss in patients undergoing brain meningioma resections: Study protocol for a randomized controlled trial
INTRODUCTION: Tranexamic acid (TXA) has been proven to prevent thrombolysis and reduce bleeding and blood transfusion requirements in various surgical settings. However, the optimal dose of TXA that effectively reduce intraoperative bleeding and blood product infusion in patients undergoing neurosur...
Autores principales: | Yu, Haojie, Liu, Minying, Zhang, Xingyue, Ma, Tingting, Yang, Jingchao, Wu, Yaru, Wang, Jie, Li, Muhan, Wang, Juan, Zeng, Min, Zhang, Liyong, Jin, Hailong, Liu, Xiaoyuan, Li, Shu, Peng, Yuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470952/ https://www.ncbi.nlm.nih.gov/pubmed/37651373 http://dx.doi.org/10.1371/journal.pone.0290725 |
Ejemplares similares
-
Safety of intravenous tranexamic acid in patients undergoing supratentorial meningiomas resection: protocol for a randomised, parallel-group, placebo control, non-inferiority trial
por: Li, Shu, et al.
Publicado: (2022) -
Risk factors for postoperative thrombosis-related complications in patients undergoing malignant brain tumor resection: a retrospective cohort study
por: Liu, Xiaoyuan, et al.
Publicado: (2023) -
Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium in elderly patients undergoing craniotomy: a protocol of randomised clinical trial
por: Cui, Qianyu, et al.
Publicado: (2023) -
Effect of intraoperative goal-directed fluid therapy on the postoperative brain edema in patients undergoing high-grade glioma resections: a study protocol of randomized control trial
por: Liu, Xiaoyuan, et al.
Publicado: (2022) -
Effect of dexmedetomidine on postoperative delirium in patients undergoing awake craniotomies: study protocol of a randomized controlled trial
por: Li, Muhan, et al.
Publicado: (2023)